Delcath Systems Stock Performance
| DCTH Stock | USD 11.25 0.07 0.62% |
The firm shows a Beta (market volatility) of 0.25, which means not very significant fluctuations relative to the market. As returns on the market increase, Delcath Systems' returns are expected to increase less than the market. However, during the bear market, the loss of holding Delcath Systems is expected to be smaller as well. Delcath Systems right now shows a risk of 4.47%. Please confirm Delcath Systems total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if Delcath Systems will be following its price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Over the last 90 days Delcath Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Delcath Systems is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 12.7 M | |
| Total Cashflows From Investing Activities | -981 K | |
| Free Cash Flow | -19.2 M |
Delcath Systems Relative Risk vs. Return Landscape
If you would invest 1,187 in Delcath Systems on April 22, 2025 and sell it today you would lose (62.00) from holding Delcath Systems or give up 5.22% of portfolio value over 90 days. Delcath Systems is currently generating 0.0065% in daily expected returns and assumes 4.4705% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than Delcath, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Delcath Systems Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Delcath Systems' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Delcath Systems, and traders can use it to determine the average amount a Delcath Systems' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0014
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DCTH |
Estimated Market Risk
| 4.47 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Delcath Systems is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Delcath Systems by adding Delcath Systems to a well-diversified portfolio.
Delcath Systems Fundamentals Growth
Delcath Stock prices reflect investors' perceptions of the future prospects and financial health of Delcath Systems, and Delcath Systems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Delcath Stock performance.
| Return On Equity | -0.28 | ||||
| Return On Asset | -0.0151 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 333.91 M | ||||
| Shares Outstanding | 34.83 M | ||||
| Price To Earning | (0.12) X | ||||
| Price To Book | 4.88 X | ||||
| Price To Sales | 7.28 X | ||||
| Revenue | 37.2 M | ||||
| EBITDA | (12.18 M) | ||||
| Cash And Equivalents | 10.2 M | ||||
| Cash Per Share | 1.19 X | ||||
| Total Debt | 1.04 M | ||||
| Debt To Equity | 3.13 % | ||||
| Book Value Per Share | 2.40 X | ||||
| Cash Flow From Operations | (18.68 M) | ||||
| Earnings Per Share | (0.45) X | ||||
| Total Asset | 76.59 M | ||||
| Retained Earnings | (531.55 M) | ||||
| Current Asset | 14.6 M | ||||
| Current Liabilities | 6.31 M | ||||
About Delcath Systems Performance
By evaluating Delcath Systems' fundamental ratios, stakeholders can gain valuable insights into Delcath Systems' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Delcath Systems has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Delcath Systems has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Delcath Systems operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 55 people.Things to note about Delcath Systems performance evaluation
Checking the ongoing alerts about Delcath Systems for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Delcath Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Delcath Systems had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 37.2 M. Net Loss for the year was (26.39 M) with profit before overhead, payroll, taxes, and interest of 45.72 M. | |
| Delcath Systems currently holds about 10.2 M in cash with (18.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.19. | |
| Delcath Systems has a frail financial position based on the latest SEC disclosures |
- Analyzing Delcath Systems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Delcath Systems' stock is overvalued or undervalued compared to its peers.
- Examining Delcath Systems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Delcath Systems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Delcath Systems' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Delcath Systems' stock. These opinions can provide insight into Delcath Systems' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Delcath Stock analysis
When running Delcath Systems' price analysis, check to measure Delcath Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delcath Systems is operating at the current time. Most of Delcath Systems' value examination focuses on studying past and present price action to predict the probability of Delcath Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delcath Systems' price. Additionally, you may evaluate how the addition of Delcath Systems to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |